Explore more publications!
Arkansas Healthcare Report
Got News to Share?

Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 17, 2025

Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
December 17, 2025

Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders

Indeterminate GlobeNewswire
Voting Rights and Shares Capital of the Company
December 17, 2025

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
December 17, 2025

CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies

Indeterminate GlobeNewswire
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 17, 2025

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

Indeterminate GlobeNewswire
Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA
December 17, 2025

Immuneering Advances Towards Dosing First Patient in Phase 3 Atebimetinib Trial for First-Line Metastatic Pancreatic Cancer Patients, Securing Alignment with FDA and EMA

Indeterminate GlobeNewswire
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
December 17, 2025

Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD

Indeterminate GlobeNewswire
Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare  
December 17, 2025

Inventiva présentera à la 44e conférence annuelle J.P. Morgan Healthcare  

Indeterminate GlobeNewswire
Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Ticket To Work Program Marks 26 Years of Supporting Workers With Disabilities, Allsup Employment Services Celebrates Impact
December 17, 2025

Ticket To Work Program Marks 26 Years of Supporting Workers With Disabilities, Allsup Employment Services Celebrates Impact

Indeterminate GlobeNewswire
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
December 17, 2025

OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates

Indeterminate GlobeNewswire
PPE Innovators Add Voice to National Campaign Supporting Women in Trades
December 17, 2025

PPE Innovators Add Voice to National Campaign Supporting Women in Trades

Indeterminate GlobeNewswire
Blood Community Unites to Thank America’s Volunteer Blood Donors as National Blood Donor Month Approaches
December 17, 2025

Blood Community Unites to Thank America’s Volunteer Blood Donors as National Blood Donor Month Approaches

Indeterminate GlobeNewswire
DeLorean AI Releases New Cardiovascular AI White Paper Showing Predictive AI Can Prevent Heart Failure and Cut Costs by Up to $350,000 Per Patient
December 17, 2025

DeLorean AI Releases New Cardiovascular AI White Paper Showing Predictive AI Can Prevent Heart Failure and Cut Costs by Up to $350,000 Per Patient

Indeterminate GlobeNewswire
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 17, 2025

Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection

Indeterminate GlobeNewswire
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy
December 17, 2025

Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy

Indeterminate GlobeNewswire
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
December 17, 2025

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

Indeterminate GlobeNewswire
UPDATE -- Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast
December 17, 2025

UPDATE -- Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

Indeterminate GlobeNewswire
Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
December 17, 2025

Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
December 17, 2025

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions